Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
N-acetylcysteine for Marijuana Cue-Reactivity
NCT03154580Phase 1Completed
- Sponsor
- Wayne State University
- Start
- May 2017
- Primary completion
- Jun 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised, double-blind trial in cannabis use disorder (CUD) comparing Placebo with N-acetylcysteine (2 arms). Primary endpoints: Marijuana Craving Visual Analog Scale, Marijuana Craving Questionnaire and 9 more. Started May 2017; status: completed.
02
Drugs
acetylcysteine
03
Conditions
cannabis use disorder (CUD)
Beyond the preview
Go deeper on NCT03154580.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03154580.